Skip to content

Lantheus to Present at Goldman Sachs Global Healthcare Conference

Lantheus Holdings, Inc. announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference. John Wiggins is set to present for the company, which focuses on radiopharmaceuticals to improve patient outcomes.

BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced John Wiggins,